• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Aegon gets “buy” rating from BofA, shares up

by November 29, 2024
written by November 29, 2024

Investing.com — Shares of Aegon (AS:AEGN) rose over 2% on Friday following an upgrade from BofA Securities, revising its rating on the company to “buy” and increased its price target to €7. 

Analysts at BofA flag Aegon’s efforts in de-risking its business and stabilizing its earnings. The company’s pledge to return excess cash over time was noted as a pivotal factor, presenting an opportunity for re-rating. 

The analysts also emphasized Aegon’s unique advantage as a beneficiary of macroeconomic conditions in the U.S., particularly given its earnings’ heavy reliance on the U.S. dollar and its operations’ sensitivity to equity markets.

Aegon is expected to benefit from the current economic environment, characterized by sustained higher interest rates in the U.S., which support sales, reinvestment rates, and capital. 

BofA analysts project a 4-6% increase in operating capital generation and a reduced cost of equity to 13%, contributing to the revised price target. These developments imply a potential total return of 25% from the current share price.

Additionally, Aegon’s capital return strategy includes initiating a €150 million share buyback program and reducing its holding cash pile from €1.7 billion to €1 billion over time. 

BofA anticipates additional buybacks totaling €600 million in 2025 and €500 million in 2026, cumulatively amounting to 37% of the company’s market capitalization within three years.

Despite the positive outlook, BofA analysts acknowledged ongoing challenges for Aegon, particularly in demonstrating growth and operational improvements. 

Success in enhancing asset management profitability and solidifying Transamerica’s market position in life insurance and retirement services could further strengthen investor sentiment and reduce the company’s cost of equity.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
StoneCo shares dip amid low Linx bids and Brazil market weakness
next post
RBC downgrades Applied Therapeutics as FDA rejects Govorestat, hacks price target

You may also like

Adani, Ambani news units sue OpenAI over copyright,...

March 13, 2026

China’s DeepSeek sets off AI market rout

March 13, 2026

BASF results down on impairments, restructuring

March 13, 2026

Nasdaq futures tumble as China’s AI push rattles...

March 13, 2026

European chipmakers slump as traders gauge DeepSeek AI...

March 13, 2026

Fuji Media, rocked by sexual misconduct allegations, says...

March 13, 2026

China Vanke’s CEO, chairman resign amid growing liquidity...

March 13, 2026

Italy’s MPS shares fall ahead of Mediobanca board...

March 13, 2026

UMG shares rally after new multi-year pact with...

March 13, 2026

British Land stock drops following stake sale

March 13, 2026
Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!








    By signing up, you're cool with getting emails from us. Don’t worry — your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    Recent Posts

    • Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears

      May 2, 2026
    • Thermos recalls 8.2 million bottles after stoppers eject, causing injury and reported vision loss

      May 2, 2026
    • The Onion’s bid to take over Alex Jones’ Infowars is in limbo as new court battles emerge

      May 2, 2026
    • Republican state attorneys general join lawsuit to stop $6.2B local TV merger

      May 1, 2026

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (737)
    • Stock (6,426)

    Latest News

    • Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears
    • Thermos recalls 8.2 million bottles after stoppers eject, causing injury and reported vision loss

    Popular News

    • Hedge funds deliver double-digit returns in 2024
    • GSK warns of lower 2024 vaccine sales after weaker RSV, shingles demand

    About The Significant deals

    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy